Ibandronate reduces skeletal morbidity in patients with breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference17 articles.
1. Metastatic bone disease;Coleman;Cancer Treat Rev,2001
2. Treatment of metastatic bone disease in breast cancer;Diel;Clin Breast Cancer,2000
3. Bisphosphonates for breast cancer;Pavlakis;Cochrane Database Syst Rev,2002
4. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer;Ross;BMJ,2003
5. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer;Hillner;J Clin Oncol,2003
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy;Seminars in Oncology;2010-10
2. Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer;European Journal of Cancer Care;2009-11
3. Drug Management of Prostate Cancer: Prevalence and Consequences of Renal Insufficiency;Clinical Genitourinary Cancer;2009-10
4. Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues;Breast Cancer Research and Treatment;2008-08-15
5. Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases;Journal of Clinical Oncology;2007-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3